Evaluation and Optimization of Lipofectamine 3000 Reagents for Transient Gene Expression in KYSE-30 Esophagus Cancer Cell Line
Archives of Medical Laboratory Sciences,
Vol. 6 (2020),
20 January 2020
,
Page 1-9 (e8)
https://doi.org/10.22037/amls.v6.31081
Abstract
Background and Aim: Transfection of DNA/RNA sequence into eukaryotic cells has a major effect on scientific studies. Various methods are used to transfer the DNA/RNA sequence into cells, such as lipid-based carriers as the available and easy procedure. Transfection with cationic lipid liposome is introduced as a simple and efficient procedure for monitoring the DNA/RNA sequence through gene function analysis, including fluorescence imaging RNA and protein expression. This study aimed to investigate the transfection efficiency and cell death through GFP expression in human esophageal squamous cell carcinoma (ESCC) cell line KYSE-30 using Lipofectamine 3000 reagent. Methods: The pCDH-513b plasmid DNA was transfected into KYSE-30 cells using Lipofectamine 3000 in different concentrations of the plasmid DNA and reagent. The transfection efficiency was evaluated by fluorescence microscope and flow cytometry analysis to determine the percentage of GFP-expressing cells. Moreover, the viability and death of transfected KYSE-30 cells were evaluated using a trypan blue exclusion assay. Results: The transfection efficiency of KYSE-30 with Lipofectamine 3000 was increased with higher plasmid DNA concentration and a lower amount of Lipofectamine 3000 reagent. The Optimized concentration of 1.5 µg plasmid DNA and volume of one µl of lipofectamine 3000 reagents were identified for 95% transfection efficiency in the KYSE-30 cell line. The viability and death of transfected cells were 43% and 58% after transfection, respectively. Conclusion: The results indicated that Lipofectamine 3000 might not be suitable for transfection in KYSE-30 cells due to increased cell death.
*Corresponding Author: Mohammad Reza Abbaszadegan; Email: abbaszadeganmr@mums.ac.ir
Please cite this article as: Mahmoudian RA, Farshchian M, Abbaszadegan MR. Evaluation and Optimization of Lipofectamine 3000 Reagents for Transient Gene Expression in KYSE-30 Esophagus Cancer Cell Line. Arch Med Lab Sci. 2019;5(4):1-9. https://doi.org/10.22037/amls.v5i4.31081
- Non-Viral Vector
- Transfection Efficiency
- Cationic Lipid
- Lipofectamine 3000
How to Cite
References
Lehner R, Wang X, Hunziker P. Plasmid linearization changes shape and efficiency of transfection complexes. European Journal of Nanomedicine. 2013;5(4):205-12.
Agi E, Mosaferi Z, Khatamsaz S, Cheraghi P, Samadian N, Bolhassani A. Different strategies of gene delivery for treatment of cancer and other disorders. Journal of Solid Tumors. 2016;6(2):76.
Wirth T, Ylä-Herttuala S. Gene therapy used in cancer treatment. Biomedicines. 2014;2(2):149-62.
Recillas-Targa F. Multiple strategies for gene transfer, expression, knockdown, and chromatin influence in mammalian cell lines and transgenic animals. Molecular biotechnology. 2006;34(3):337-54.
Sou SN, Polizzi KM, Kontoravdi C. Evaluation of transfection methods for transient gene expression in Chinese hamster ovary cells. Advances in Bioscience and Biotechnology. 2013;4(12):1013.
Kim TK, Eberwine JH. Mammalian cell transfection: the present and the future. Analytical and bioanalytical chemistry. 2010;397(8):3173-8.
Khan K. Gene transfer technologies and their applications: roles in human diseases. Asian Journal of Experimental Biological Science. 2010;1(2):208-18.
Lee M, Chea K, Pyda R, Chua M, Dominguez I. Comparative Analysis of Non-viral Transfection Methods in Mouse Embryonic Fibroblast Cells. Journal of Biomolecular Techniques: JBT. 2017;28(2):67.
Kaestner L, Scholz A, Lipp P. Conceptual and technical aspects of transfection and gene delivery. Bioorganic & medicinal chemistry letters. 2015;25(6):1171-6.
Dalby B, Cates S, Harris A, Ohki EC, Tilkins ML, Price PJ, et al. Advanced transfection with Lipofectamine 2000 reagent: primary neurons, siRNA, and high-throughput applications. Methods. 2004;33(2):95-103.
Douzandegan Y, Gray Z, Mohebbi A, Moradi A, Tabarraei A. Original Research Article Optimization of KYSE-30 Esophagus Cancer Cell Line Transfection Using Lipofectamine 2000.
Yamano S, Dai J, Moursi AM. Comparison of transfection efficiency of nonviral gene transfer reagents. Molecular biotechnology. 2010;46(3):287-300.
Shi B, Xue M, Wang Y, Wang Y, Li D, Zhao X, et al. An improved method for increasing the efficiency of gene transfection and transduction. International journal of physiology, pathophysiology and pharmacology. 2018;10(2):95.
Douzandegan Y, Gray Z, Mohebbi A, Moradi A, Tabarraei A. Optimization of KYSE-30 Esophagus Cancer Cell Line Transfection Using Lipofectamine 2000. Journal of Clinical and Basic Research. 2017;1(2):16-20.
Abràmoff MD, Magalhães PJ, Ram SJ. Image processing with ImageJ. Biophotonics international. 2004;11(7):36-42.
Strober W. Trypan blue exclusion test of cell viability. Current protocols in immunology. 2015;111(1):A3. B. 1-A3. B. .
Strober W. Trypan blue exclusion test of cell viability. Current protocols in immunology. 1997;21(1):A. 3B. 1-A. 3B. 2.
Wang T, Larcher L, Ma L, Veedu R. Systematic screening of commonly used commercial transfection reagents towards efficient transfection of single-stranded oligonucleotides. Molecules. 2018;23(10):2564.
Xia W, Bringmann P, McClary J, Jones PP, Manzana W, Zhu Y, et al. High levels of protein expression using different mammalian CMV promoters in several cell lines. Protein expression and purification. 2006;45(1):115-24.
Sung Y, Kim S. Recent advances in the development of gene delivery systems. Biomaterials research. 2019;23(1):8.
Jones CH, Chen C-K, Ravikrishnan A, Rane S, Pfeifer BA. Overcoming nonviral gene delivery barriers: perspective and future. Molecular pharmaceutics. 2013;10(11):4082-98.
Cardarelli F, Digiacomo L, Marchini C, Amici A, Salomone F, Fiume G, et al. The intracellular trafficking mechanism of Lipofectamine-based transfection reagents and its implication for gene delivery. Scientific reports. 2016;6:25879.
Sarkar K, Meka SRK, Madras G, Chatterjee K. A self-assembling polycationic nanocarrier that exhibits exceptional gene transfection efficiency. RSC Advances. 2015;5(111):91619-32.
Tamm C, Kadekar S, Pijuan-Galitó S, Annerén C. Fast and efficient transfection of mouse embryonic stem cells using non-viral reagents. Stem Cell Reviews and Reports. 2016;12(5):584-91.
Yu X, Liang X, Xie H, Kumar S, Ravinder N, Potter J, et al. Improved delivery of Cas9 protein/gRNA complexes using lipofectamine CRISPRMAX. Biotechnology letters. 2016;38(6):919-29.
Liang X, Potter J, Kumar S, Zou Y, Quintanilla R, Sridharan M, et al. Rapid and highly efficient mammalian cell engineering via Cas9 protein transfection. Journal of biotechnology. 2015;208:44-53.
Rust A, Hassan HH, Sedelnikova S, Niranjan D, Hautbergue G, Abbas SA, et al. Two complementary approaches for intracellular delivery of exogenous enzymes. Scientific reports. 2015;5:12444.
Yang L, Wang X, Deng W, Mo W, Gao J, Liu Q, et al. Using HEK293T expression system to study photoactive plant cryptochromes. Frontiers in Plant Science. 2016;7:940.
Li K, Wang G, Andersen T, Zhou P, Pu WT. Optimization of genome engineering approaches with the CRISPR/Cas9 system. PloS one. 2014;9(8):e105779.
Qin J, Wang F, Jiang H, Xu J, Jiang Y, Wang Z. MicroRNA-145 suppresses cell migration and invasion by targeting paxillin in human colorectal cancer cells. International journal of clinical and experimental pathology. 2015;8(2):1328.
Jiang L, Zhao Z, Zheng L, Xue L, Zhan Q, Song Y. Downregulation of miR-503 promotes ESCC cell proliferation, migration, and invasion by targeting cyclin D1. Genomics, proteomics & bioinformatics. 2017;15(3):208-17.
Zhao H, Diao C, Wang X, Xie Y, Liu Y, Gao X, et al. MiR-543 promotes migration, invasion and epithelial-mesenchymal transition of esophageal cancer cells by targeting phospholipase A2 group IVA. Cellular Physiology and Biochemistry. 2018;48(4):1595-604.
Sharma P, Saini N, Sharma R. miR-107 functions as a tumor suppressor in human esophageal squamous cell carcinoma and targets Cdc42. Oncology reports. 2017;37(5):3116-27.
Han Y, Yang X, Zhao N, Peng J, Gao H, Qiu X. Alpinumisoflavone induces apoptosis in esophageal squamous cell carcinoma by modulating miR-370/PIM1 signaling. American journal of cancer research. 2016;6(12):2755.
He Z, Li G, Tang L, Li Y. SIX1 overexpression predicts poor prognosis and induces radioresistance through AKT signaling in esophageal squamous cell carcinoma. OncoTargets and therapy. 2017;10:1071.
Rao S, Morales AA, Pearse DD. The comparative utility of viromer RED and lipofectamine for transient gene introduction into glial cells. BioMed research international. 2015;2015.
Wang Y, Shang S, Li C. Comparison of different kinds of nonviral vectors for gene delivery to human periodontal ligament stem cells. Journal of Dental Sciences. 2015;10(4):414-22.
Almulathanon AA, Ranucci E, Ferruti P, Garnett MC, Bosquillon C. Comparison of gene transfection and cytotoxicity mechanisms of linear poly (amidoamine) and branched poly (ethyleneimine) polyplexes. Pharmaceutical research. 2018;35(4):86.
Romøren K, Thu BJ, Bols NC, Evensen Ø. Transfection efficiency and cytotoxicity of cationic liposomes in salmonid cell lines of hepatocyte and macrophage origin. Biochimica et Biophysica Acta (BBA)-Biomembranes. 2004;1663(1-2):127-34.
Thienpont B, Aronsen JM, Robinson EL, Okkenhaug H, Loche E, Ferrini A, et al. The H3K9 dimethyltransferases EHMT1/2 protect against pathological cardiac hypertrophy. The Journal of clinical investigation. 2017;127(1):335-48.
Neuhaus B, Tosun B, Rotan O, Frede A, Westendorf AM, Epple M. Nanoparticles as transfection agents: a comprehensive study with ten different cell lines. Rsc Advances. 2016;6(22):18102-12.
Wang T, Shigdar S, Al Shamaileh H, Gantier MP, Yin W, Xiang D, et al. Challenges and opportunities for siRNA-based cancer treatment. Cancer letters. 2017;387:77-83.
Ward CM, Stern PL. The human cytomegalovirus immediate‐early promoter is transcriptionally active in undifferentiated mouse embryonic stem cells. Stem cells. 2002;20(5):472-5.
Mahmoudian RA, Bahadori B, Rad A, Abbaszadegan MR, Forghanifard MM. MEIS1 knockdown may promote differentiation of esophageal squamous carcinoma cell line KYSE‐30. Molecular genetics & genomic medicine. 2019:e746.
- Abstract Viewed: 1140 times
- PDF Downloaded: 381 times